210 related articles for article (PubMed ID: 28893609)
1. Supramolecular cisplatin-vorinostat nanodrug for overcoming drug resistance in cancer synergistic therapy.
Xu S; Zhu X; Huang W; Zhou Y; Yan D
J Control Release; 2017 Nov; 266():36-46. PubMed ID: 28893609
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anticancer activity of combined histone deacetylase and proteasomal inhibitor-loaded zein nanoparticles in metastatic prostate cancers.
Thapa RK; Nguyen HT; Jeong JH; Shin BS; Ku SK; Choi HG; Yong CS; Kim JO
Nanomedicine; 2017 Apr; 13(3):885-896. PubMed ID: 27993720
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
4. Construction of redox-responsive tumor targeted cisplatin nano-delivery system for effective cancer chemotherapy.
Jia YY; Zhang JJ; Zhang YX; Wang W; Li C; Zhou SY; Zhang BL
Int J Pharm; 2020 Apr; 580():119190. PubMed ID: 32151664
[TBL] [Abstract][Full Text] [Related]
5. A facile route to form self-carried redox-responsive vorinostat nanodrug for effective solid tumor therapy.
Han L; Wang T; Wu J; Yin X; Fang H; Zhang N
Int J Nanomedicine; 2016; 11():6003-6022. PubMed ID: 27956831
[TBL] [Abstract][Full Text] [Related]
6. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-Stitched Polysaccharide Vesicles for Synergistic Cancer Therapy of Triple Antagonistic Drugs.
Deshpande NU; Jayakannan M
Biomacromolecules; 2017 Jan; 18(1):113-126. PubMed ID: 28064505
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-stitched α-poly(glutamatic acid) nanoconjugate for enhanced safety and effective tumor inhibition.
Wang H; Xiong Y; Wang R; Yu Y; Wang J; Hu Z; Sun C; Tu J; He D
Eur J Pharm Sci; 2018 Jul; 119():189-199. PubMed ID: 29678612
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of Vorinostat and Etoposide Via Disulfide Cross-Linked Biodegradable Polymeric Nanogels: Synthesis, Characterization, Biodegradation, and Anticancer Activity.
Kumar P; Wasim L; Chopra M; Chhikara A
AAPS PharmSciTech; 2018 Feb; 19(2):634-647. PubMed ID: 28948528
[TBL] [Abstract][Full Text] [Related]
11. Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance.
Song W; Tang Z; Shen N; Yu H; Jia Y; Zhang D; Jiang J; He C; Tian H; Chen X
J Control Release; 2016 Jun; 231():94-102. PubMed ID: 26928530
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibition restores cisplatin sensitivity of Hodgkin's lymphoma cells.
Kewitz S; Bernig T; Staege MS
Leuk Res; 2012 Jun; 36(6):773-8. PubMed ID: 22424710
[TBL] [Abstract][Full Text] [Related]
13. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
Mou Q; Ma Y; Zhu X; Yan D
J Control Release; 2016 May; 230():34-44. PubMed ID: 27040815
[TBL] [Abstract][Full Text] [Related]
14. Double-crosslinked nanocomposite hydrogels for temporal control of drug dosing in combination therapy.
Wu C; Liu J; Zhai Z; Yang L; Tang X; Zhao L; Xu K; Zhong W
Acta Biomater; 2020 Apr; 106():278-288. PubMed ID: 32084599
[TBL] [Abstract][Full Text] [Related]
15. Development of vorinostat-loaded solid lipid nanoparticles to enhance pharmacokinetics and efficacy against multidrug-resistant cancer cells.
Tran TH; Ramasamy T; Truong DH; Shin BS; Choi HG; Yong CS; Kim JO
Pharm Res; 2014 Aug; 31(8):1978-88. PubMed ID: 24562809
[TBL] [Abstract][Full Text] [Related]
16. Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy.
Chiang CS; Tseng YH; Liao BJ; Chen SY
Adv Healthc Mater; 2015 May; 4(7):1066-75. PubMed ID: 25656800
[TBL] [Abstract][Full Text] [Related]
17. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
[TBL] [Abstract][Full Text] [Related]
18. Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells.
Huang WT; Larsson M; Lee YC; Liu DM; Chiou GY
Eur J Pharm Biopharm; 2016 Dec; 109():165-173. PubMed ID: 27793756
[TBL] [Abstract][Full Text] [Related]
19. Reporter nanoparticle that monitors its anticancer efficacy in real time.
Kulkarni A; Rao P; Natarajan S; Goldman A; Sabbisetti VS; Khater Y; Korimerla N; Chandrasekar V; Mashelkar RA; Sengupta S
Proc Natl Acad Sci U S A; 2016 Apr; 113(15):E2104-13. PubMed ID: 27036008
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of cisplatin efficacy by lipid-CaO
He C; Zhang X; Yan R; Zhao P; Chen Y; Li M; Chen C; Fan T; Lu Y; Wang C; Wu F; Lee RJ; Yang T; Xiang G
Biomater Sci; 2019 Oct; 7(10):4260-4272. PubMed ID: 31402373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
